BSECompany UpdateResults2h ago
Mangalam Drugs & Organics Ltd
Disclosure pursuant to Regulation 30 LODR, 2025 for approval and consideration by Board of Directors at Meeting held on 18.11.2026 of the Company for undertaking of Financial Restructuring and exploring of various strategic options and convening of EGM to seek members approval to take fesiable action in the aforesaid matter.
Mangalam Drugs & Organics Ltd has disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that its Board of Directors has approved a proposal for financial restructuring and exploring various strategic options, including the potential sale/disposal of its leasehold land rights and building. The company has not entered into any definitive agreement or arrangement for the proposed sale/disposal. An Extra-Ordinary General Meeting (EGM) of the Members of the Company will be convened to seek their approval, wherever required under applicable laws.
BSEGeneralExpansion3h ago
Mangalam Drugs & Organics Ltd
Outcome of Board Meeting pursuant to Regulation 30 of SEBI LODR, 2015 to consider and approve of financial restructuring , exploring strategic options and convening of EGM of the Company
Mangalam Drugs & Organics Ltd has announced that its board of directors has approved a proposal for financial restructuring and exploring strategic options, including the potential sale/disposal of its leasehold land rights and building in Vapi, Gujarat. The company has not entered into any definitive agreement and the proposal is at an exploratory stage.
BSEGeneralResults3h ago
Mangalam Drugs & Organics Ltd
Outcome of Board Meeting pursuant to Regulation 30 of SEBI LODR, 2015 to consider and approve of financial restructuring , exploring strategic options and convening of EGM of the Company
Mangalam Drugs & Organics Ltd's board approved financial restructuring, exploring strategic options, and convening an EGM to seek approval for the proposed sale/disposal of its leasehold land rights and building. The proposal is at an exploratory stage, and no definitive agreement has been entered into. The expected date of completion is uncertain and will depend on identifying a suitable buyer, finalizing commercial terms, and obtaining requisite approvals.
BSEGeneral▼ NegativeDebt Restruc.2d ago
Mangalam Drugs & Organics Ltd
Subsequent Intimation of Bank Deafult in Pursuant to Regulation 30 Para A of SEBI (LODR), 2015
Mangalam Drugs & Organics Ltd has made a subsequent intimation to the stock exchanges regarding default on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days. The company has outstanding balances in excess of the sanctioned limits for more than 30 days, as per the regulations of the exchange.
BSEGeneral▼ NegativeDebt Restruc.2d ago
Mangalam Drugs & Organics Ltd
Subsequent Intimation of Bank Deafult in Pursuant to Regulation 30 Para A of SEBI (LODR), 2015
Mangalam Drugs & Organics Ltd has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of the exchange.
BSECompany UpdateResults6 Nov 2026
Mangalam Drugs & Organics Ltd
Intimation for Newspaper Publication of unaudited Financial Results (Consolidated and Standalone ) for the quarter ended September 30, 2026 in Financial Express and Marathi Lokstta.
Mangalam Drugs & Organics Ltd has announced unaudited financial results for the quarter ended September 30, 2026, which have been approved by the Board of Directors. The results will be published in Financial Express and Loksatta newspapers.
BSEResultResults5 Nov 2026
Mangalam Drugs & Organics Ltd
Declaration of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 3026 along with Limited Review Report.
Mangalam Drugs & Organics Ltd has declared its unaudited financial results for the quarter and half year ended September 30, 2026, with the statutory auditors not expressing any modified opinion in their Limited Review Reports.
BSEBoard MeetingResults5 Nov 2026
Mangalam Drugs & Organics Ltd
Disclsoure of Outcome of Board Meeting pursuant to Regulation 30 of SEBI (LODR), 2015 for declaration of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026
Mangalam Drugs & Organics Ltd announces unaudited financial results for the quarter and half year ended September 30, 2026, with the Board of Directors approving the results and a limited review report from the company's auditors.
BSECompany Update4 Nov 2026
Mangalam Drugs & Organics Ltd
Intimation under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015 - Dispatch of Letter for Non- Email Cases
Mangalam Drugs & Organics Ltd has dispatched a letter to non-email registered shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015, regarding the 53rd Annual General Meeting and Annual Report for the Financial Year 2025-26.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs & Organics Ltd
Intimation for members consent received under Regulation 30 of SEBI (LODR), 2015 for appointment of Mr. Prabhakar Zavar as an Independent Director wef. September 15 2026 for term of 5 years, who has attained age of 78 years
Mangalam Drugs & Organics Ltd has announced that its members have approved the appointment of Mr. Prabhakar Raghunath Zavar as an Independent Director for a term of 5 years, with 98.28% of votes in favor.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has announced the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change2 Nov 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.